glutathione mutations in sclc patients Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs therapy Oncology Letters
Oncology Letters Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of Oncology Reports JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




